Waning Immunity after the BNT162b2 Vaccine in Israel

BACKGROUND: In December 2020, Israel began a mass vaccination campaign against coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to a sharp curtailing of the outbreak. After a period with almost no cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Freedman, Laurence, Haas, Eric J., Milo, Ron, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609604/
https://www.ncbi.nlm.nih.gov/pubmed/34706170
http://dx.doi.org/10.1056/NEJMoa2114228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609604/
https://www.ncbi.nlm.nih.gov/pubmed/34706170
http://dx.doi.org/10.1056/NEJMoa2114228

Ejemplares similares